Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in inflammatory pathways and cancer progression. Shows promising activity in modulating immune responses and suppressing tumor cell growth in preclinical models. Investigated for development in targeted therapies for autoimmune diseases and certain solid tumors. Its structure allows for high selectivity and binding affinity to ATP-binding sites of kinases, making it a valuable scaffold in drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in novel therapeutic agents.